Contrary to popular belief, curing a disease can be more economically valuable than relying on ongoing monthly treatments. Recent findings show that a one-time cure, achieving the same patient outcomes without recurring prescriptions, can offer over twice the financial return. Chief Futurist Brett Winton covers more on The Brainstorm.
|
Join ARK Invest and Mach33 live, Monday ...
Anthropic filed for its long-awaited IPO...
Emma Johnston, Senior Quantitative Strat...
SpaceX has secured a massive forty billi...
Berkshire Hathaway rallied 9.3% in Octob...
Walmart is expanding its healthcare foot...
Hyperscaler artificial intelligence inve...
Retail trading activity has plummeted 45...
Bloomberg’s Ed Ludlow takes a look at An...
Anthropic’s IPO will finally give public...
Menlo Ventures’ investment in Anthropic ...
Meta Platforms Inc. is seeking to raise ...
<2026年10月22日(木)開催> ▼ハッチの米国株マーケットセミナー(口座...
※セミナーでは銘柄スカウターを使った銘柄探し手法についてご紹介していますが、マネ...